The BMA is critical of proposals to ban puberty blockers for children with gender dysphoria, advocating for more research to form a solid evidence base for children's care.
The BMA calls for a pause in implementing the Cass Review's recommendations, emphasizing the importance of scrutinizing the report in the specialized area of healthcare for children and young adults.
[
Collection
]
[
|
...
]